Filter
2330
Filtered Results: 2330
Text search:
regimens
Featured
Recommendations
240
New Publications
604
Language
Document type
No document type
1456
Guidelines
356
Studies & Reports
283
Manuals
79
Fact sheets
49
Strategic & Response Plan
47
Training Material
25
Infographics
18
Situation Updates
9
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
137
South Africa
72
Global
70
Kenya
56
Ethiopia
55
Tanzania
50
Western and Central Europe
43
Uganda
38
Zambia
37
Nigeria
36
Africa
35
Nepal
34
Malawi
31
Latin America and the Carribbean
31
Eastern Europe
31
Rwanda
29
Liberia
25
Ghana
24
Philippines
24
Ukraine
23
Bangladesh
20
Namibia
20
Indonesia
19
Zimbabwe
18
Myanmar / Burma
18
Cambodia
17
Asia
17
South–East Asia Region
16
Mozambique
14
Russia
14
Sierra Leone
13
Botswana
12
Lesotho
11
Senegal
10
West and Central Africa
10
Brazil
9
Colombia
9
East and Southern Africa
9
Eswatini/ Swaziland
8
Middle East and North Africa
8
Congo, Democratic Republic of
7
Cameroon
7
Germany
7
Syria
7
Thailand
7
Paraguay
6
Venezuela
6
Georgia
6
Haiti
5
Pakistan
5
Argentina
5
Western Pacific Region
5
Albania
5
Tajikistan
5
USA
4
South Sudan
4
Benin
4
Vietnam
4
Somalia
3
Afghanistan
3
China
3
Peru
3
Eastern Europe and Central Asia
3
Bhutan
3
Estonia
3
Jamaica
3
Guinea
2
Burkina Faso
2
Iraq
2
Jordan
2
Sudan
2
North Macedonia
2
Bolivia
2
Sri Lanka
2
Laos
2
Timor Leste/ East Timor
2
Romania
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Central African Republic
1
Serbia
1
El Salvador
1
Greece
1
Chile
1
Yemen
1
Other region
1
Fiji
1
Solomon Islands
1
North Korea
1
Armenia
1
Moldova
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
835
Clinical Guidelines
340
Public Health
108
Women & Child Health
101
Capacity Building
51
Key Resources
21
Pharmacy & Technologies
18
Toolboxes
HIV
412
TB
382
COVID-19
93
NTDs
87
AMR
79
Pharmacy
63
NCDs
60
Mental Health
54
Caregiver
43
Ebola
34
Refugee
27
Rapid Response
26
Conflict
19
Cholera
13
Polio
13
Disability
11
Planetary Health
10
Natural Hazards
7
Health Financing Toolbox
6
Specific Hazards
5
Global Health Education
4
Social Ethics
4
Zika
2
Chagas is a parasitic disease that affects over 6 million people in the
world. As the disease typically remains asymptomatic for years, new cases
often go unnoticed and unreported, and most people with the disease
are unaware of their condition. Less than 10% of people affected are
diagnosed and...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
The new WHO recommendations for rabies immunization supersede the 2010 WHO position
on pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for rabies. These updated
recommendations are based on new evidence and directed by public health needs that are cost-,
dose- and time-sparing...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
This Global Plan builds on the previous edition, which laid out priority actions for 2018-2022, informed by global commitments member states endorsed at the 2018 United Nations High-Level Meeting (UNHLM) on TB. The resource needs estimates from this Global Plan include resources needed for implement...
Review Article: Journal of Nutritional Health & Food Science
Vitamin Deficiency and Tuberculosis: Need for Urgent Clinical Page 1- 6
Thirty-three years after its discovery, the Human Immunodeficiency Virus (HIV), responsible for the AIDS pandemic, remains a major public health problem despite advanced researches providing better diagnostic and therapeutic tools. The virus targets especially CD4+ T cells, leading to deficiency of ...
